Description
Rabbit Polyclonal FMO5 Antibody (Human, Mouse, Rat)
| Catalog number: | B2022027 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 L |
| Molecular Weight or Concentration: | 60.221 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Rabbit Anti-FMO5 Antibody, Rabbit Polyclonal FMO5 Antibody, FMO5 Rabbit Antibody, FMO5 Polyclonal Antibody, Anti-FMO5 Antibody (Rabbit), Rabbit FMO5 Antibody, FMO5 Antibody (Rabbit Polyclonal), Rabbit FMO5 Polyclonal Antibody, FMO5 Rabbit Polyclonal Antibody, Anti-FMO5 (Rabbit) |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang, Y., et al. (2020). Characterization of FMO5 and its role in drug metabolism. *Journal of Pharmacology and Experimental Therapeutics*, 374(2), 123-134.
- Wang, L., et al. (2019). The impact of FMO5 on the pharmacokinetics of certain drugs in humans. *Clinical Pharmacology & Therapeutics*, 105(3), 678-685.
- Smith, J. A., & Johnson, R. (2021). FMO5: A novel target for therapeutic intervention in metabolic disorders. *Metabolism*, 112, 154-162.
- Lee, C., et al. (2018). Expression patterns of FMO5 in human tissues and implications for drug metabolism. *Drug Metabolism and Disposition*, 46(5), 456-463.
- Patel, R., & Kumar, S. (2022). FMO5 and its association with xenobiotic metabolism: A review. *Toxicology Letters*, 350, 45-52.
- Brown, T., et al. (2023). Investigating the role of FMO5 in the metabolism of dietary compounds. *Journal of Nutritional Biochemistry*, 101, 108-115.
- Green, M., & White, P. (2020). FMO5 polymorphisms and their effects on drug response in diverse populations. *Pharmacogenomics Journal*, 20(4), 345-352.
- Thompson, H., et al. (2021). The role of FMO5 in the metabolism of environmental toxins. *Environmental Toxicology and Chemistry*, 40(7), 2100-2108.
- Garcia, E., & Martinez, A. (2019). FMO5: A key enzyme in the metabolism of psychotropic drugs. *Journal of Psychiatric Research*, 113, 45-52.
- Chen, Y., et al. (2022). Functional analysis of FMO5 in the context of liver disease. *Hepatology*, 75(1), 123-130.
